Literature DB >> 22052273

Treatment of vitiligo with a melanocyte-keratinocyte cell suspension versus dermabrasion only: a pilot study with a 12-month follow up.

Osvaldo Tomás Vázquez-Martínez1, Herminia G Martínez-Rodríguez, Leobardo Velásquez-Arenas, Dolores Baños-González, Rocío Ortíz-López, Gerardo Padilla-Rivas, Oliverio Welsh, Jorge Ocampo-Candiani.   

Abstract

BACKGROUND: Dermabrasion is a surgical procedure that has been used for repigmentation; however, autologous transplantation of uncultured melanocytes in a suspension combined with the use of adjunct treatment provides better results.
PURPOSE: To evaluate the clinical effectiveness of dermoabrasion (DA) and melanocyte-keratinocyte cell suspension transplantation (DA+MKT) vs. dermabrasion with no adjunct treatment.
MATERIALS AND METHODS: We selected 11 patients (six women and five men) with stable vitiligo. From these, two achromic maculae of similar size were selected. One macule was treated with DA+MKT and the other with DA only. The main parameter of treatment efficacy was the percentage of repigmentation in the area treated, three and 12 months after implantation.
RESULTS: In seven of the 11 patients, slightly better pigmentation occurred with DA+MKT. Two of these patients had a repigmentation greater than 50 percent and in two other patients, the result was similar for both techniques, although slightly better with MKT. Two more patients showed less than 20 percent repigmentation, but only in the area treated with DA+MKT. One patient showed pigmentation initially after DA+MKT only, and subsequent depigmentation.
CONCLUSION: DA+MKT produced slightly better repigmentation than DA only when given without adjunct treatment in a 12-month follow-up period.

Entities:  

Mesh:

Year:  2011        PMID: 22052273

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  5 in total

Review 1.  Hair Follicle as a Source of Pigment-Producing Cells for Treatment of Vitiligo: An Alternative to Epidermis?

Authors:  Mahshid Ghasemi; Amir Bajouri; Saeed Shafiiyan; Nasser Aghdami
Journal:  Tissue Eng Regen Med       Date:  2020-10-09       Impact factor: 4.169

Review 2.  Cell therapy in dermatology.

Authors:  Gabriela Petrof; Alya Abdul-Wahab; John A McGrath
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

Review 3.  Autologous non-cultured melanocyte-keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives.

Authors:  Dalia Bassiouny; Samia Esmat
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-26

4.  A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.

Authors:  Dimin Zhang; Xiaodong Wei; Weisong Hong; Lifang Fu; Guopei Qian; Ai-E Xu
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

5.  Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.

Authors:  V S Narayan; L L C van den Bol; N van Geel; M W Bekkenk; R M Luiten; A Wolkerstorfer
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-02-12       Impact factor: 6.166

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.